Choice of modality: CT or MRI
Dynamic imaging can be performed using X-rays or a magnetic field. Each approach has its own characteristics.
- Computed tomography (CT): This method is widely available, relatively inexpensive, and easily standardized. Its main limitation is the radiation burden (ionizing radiation). Because of this, physicians must limit the frame rate to avoid exceeding the patient's permissible radiation dose, which reduces temporal resolution.
- Magnetic resonance imaging (MRI): Does not use X-rays, so the image acquisition rate is not limited by radiation exposure. MRI provides exceptionally high contrast resolution. However, the method carries risks with repeated administration of gadolinium-based contrast agents, its results are more difficult to reproduce, and quantitative data analysis is mathematically more challenging compared to CT.
Contrast agent kinetics
For computed tomography, low-molecular-weight agents (mass less than 1 kDa) derived from iodobenzoic acid are used. The iodine concentration in these agents is approximately 300 mg/mL. They are administered intravenously at a high rate (at least 4 mL/s) and practically do not bind to serum proteins.
The behavior of the agent in tissues is described by a two-compartment pharmacokinetic model:
- Intravascular compartment (Intravascular compartment): The primary vascular bed where the injected bolus enters.
- Extravascular extracellular space (EES): The environment into which the contrast agent diffuses from the capillaries. The rate of this transfer depends on the organ's perfusion level, vascular surface area, and vessel permeability. The transfer of the agent into the intracellular space is negligible.
Following distribution, the agent returns from the EES back into the bloodstream and is filtered primarily by the kidneys.
Data acquisition protocol and curve analysis
Changes in tissue X-ray attenuation on CT are directly proportional to the iodine concentration. A specialized scanning protocol is used to capture these changes:
- Preliminary planning of the examination.
- Intravenous injection of the contrast agent.
- First-pass phase (First pass): Scanning with a short interval (less than 2 seconds). A high frame rate is maintained for the first 45 seconds to capture the perfusion peak.
- Delayed phase (Delayed phase): Scanning with increased intervals (5–15 seconds).
Throughout the examination, it is necessary to maintain a balance between image quality (temporal resolution) and radiation dose.
The results are evaluated semi-quantitatively (based on the curve shape) and quantitatively (using mathematical models such as the Patlak method, the maximum slope model, or the modified Johnson-Wilson model). A time-density curve is plotted, showing density in Hounsfield units (HU) versus time in seconds.
Types of enhancement curves:
- Arterial curve: Characterized by a sharp and very high peak. For example, density in the aorta can rapidly reach 800 HU.
- Tissue curve: Demonstrates a smooth and significantly less pronounced rise. In lung cancer tissue, the maximum density will be around 45 HU.
Calculated hemodynamic parameters
Based on kinetic modeling, software calculates a number of critical quantitative parameters reflecting the tumor's vascular network status:
- Regional tumor blood flow: The volume of blood flowing through a unit volume or mass of pathological tissue.
- Regional blood volume in the tumor: The fraction of tissue through which blood physically flows.
- Mean transit time: The average time required for the contrast agent to traverse the vascular bed of the region of interest.
- Extraction fraction: The rate at which the contrast agent leaves the intravascular space and enters the EES.
- Permeability-surface area product: A comprehensive indicator characterizing the rate of contrast diffusion across the vessel wall.
Briefly: answers to topical questions
What are the absolute contraindications to the administration of iodinated contrast agents?
Sources do not confirm the existence of absolute contraindications to the administration of iodinated contrast agents. Impaired renal function is not an absolute contraindication when there are clear medical indications, although contrast administration should be avoided if the eGFR is less than 30 mL/min/1.73 m². An allergy to iodinated contrast agents may be a reason to choose MRI over contrast-enhanced CT, but its absolute nature is not stated in the sources.
What specific complications are caused by the repeated administration of gadolinium-based contrast agents?
Specific complications of gadolinium-based contrast agents include:
- Nephrogenic systemic fibrosis (nephrogenic systemic fibrosis) — associated with the use of gadolinium.
- Gadolinium deposition (gadolinium deposition) — in brain structures following contrast-enhanced MRI.
Sources also describe rare toxic encephalopathy following intravenous or intrathecal administration of gadolinium in patients with acute renal failure, though its specific link to repeated administration is not specified.
In which diseases is dynamic contrast-enhanced CT indicated?
Main clinical applications of dynamic contrast-enhanced CT:
- evaluating the efficacy of anti-angiogenic (antivascular) drugs;
- evaluating the efficacy of vascular interventional procedures.
Sources do not provide a list of specific diseases for which dynamic contrast-enhanced CT is indicated.
What else to study on this topic
- Mathematical basis of the Patlak method
- Application of the modified Johnson-Wilson model in CT perfusion
- Algorithm for calculating the permeability-surface area product
- Criteria for evaluating anti-angiogenic drug efficacy using dynamic CT data
- Specific risks of gadolinium-based contrast agents
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Dynamic contrast-enhanced imaging" and 2,199 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the "Diagnostic Radiology in Oncology" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.